Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03533413
Other study ID # Raafat-Ehab.combined
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 1, 2017
Est. completion date November 30, 2017

Study information

Verified date May 2018
Source National Cancer Institute, Egypt
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

In the current study, extra-guidance other than conventional fluoroscopy - will be integrated to improve the success of the transforaminal approach to the thoracic dorsal root ganglia (DRG). The investigators hypothesize that joining CT scan with fluoroscopy to guide RF ablation through the transforaminal route may enhance its efficacy and safety in relieving the intractable pain associated with chest malignancies. The current study aimed to compare the results of thermal radiofrequency ablation (TRFA) of the thoracic DRG under combined CT and fluoroscopy guidance with the classic standard fluoroscopy technique.


Description:

Thoracic pain represents about 3-5% of pain clinics' visitors worldwide .Post-thoracotomy pain occurs in 30%-50% of patients undergoing thoracotomy .Interventional therapies include epidural or intrathecal drug injection, intercostal nerve block, sympathectomy, rhizotomy, and percutaneous cervical cordotomy. Rhizotomy refers to the selective segmental destruction of the dorsal sensory rootlets to interrupt pain perception by the spinal cord. This could be accomplished either neurosurgically, chemically or using selective percutaneous procedures such as cryoanalgesia and radiofrequency (RF) ablation.There are many technical difficulties in approaching the deep-seated thoracic dorsal root ganglia (DRG) through the transforaminal route.The spine is kyphotic - with the tip at T6 - and slightly scoliotic to the right side even in normal subjects . Spinous processes are acute, especially at T5-T8 level. Besides, broad and wide laminae together with narrow intervertebral foramina are other obstacles .The intervertebral foramina are further masked by the facet joints and the crowdedness of the costovertebral and the costotransverse joints .For all these factors, more guidance - other than conventional fluoroscopy - may improve the success of the transforaminal approach to the thoracic DRG. The investigators hypothesize that joining CT scan with fluoroscopy to guide RF ablation through the transforaminal route can enhance its efficacy and safety in relieving the intractable pain of chest malignancies. The current study aimed to compare the results of thermal radiofrequency ablation (TRFA) of the thoracic DRG under combined CT and fluoroscopy guidance with the classic standard fluoroscopy technique.


Recruitment information / eligibility

Status Completed
Enrollment 78
Est. completion date November 30, 2017
Est. primary completion date October 31, 2017
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- patients aged 18 years or more

- suffering from chronic moderate-to-severe pain ( VAS score = 40 mm)

- due to malignancy involving the chest and pain was refractory to the maximally tolerated dose of opioids for at least four weeks. Malignancies included : lung cancer, pleural mesothelioma, chest wall tumors and metastatic deposits of the chest.

Exclusion Criteria:

- sepsis, coagulopathy

- malignant epidural invasion

- distorted local anatomy

- severe cardiorespiratory compromise

- neuropsychiatric illness

- history of drug dependence and known allergy to contrast media or the used medications.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
combined CT-fluroscopy
Radiofrequency ablation of thoracic dorsal root ganglia guided by combined CT-Fluroscopy
standard fluroscopy
Radiofrequency ablation of thoracic dorsal root ganglia guided by standard fluroscopy only

Locations

Country Name City State
Egypt Department of Anesthesia and Pain medicine.National Cancer Institute Cairo

Sponsors (1)

Lead Sponsor Collaborator
National Cancer Institute, Egypt

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary pain relief. Pain intensity measured by visual analog scale (VAS).It measures the pain intensity and percentage of pain relief.The investigators used 100 mm horizontal scale with left zero end representing no pain and right 100 end representing worst pain.Scores ranging 0-39 reflect mild pain , 40-69 moderate pain and 70-100 severe pain. 12 weeks follow up
Secondary patient satisfaction. The secondary outcome measure will be assessed using patient satisfaction with the patient global impression of changes (PGIC).It measures the degree of patient overall satisfaction after the performed procedure. It includes 7 domains ranging from 1 to 7. the first domain indicates that the patient is very much improved while the 7th domain indicates that he is very much worsened by the procedure. 12 weeks
See also
  Status Clinical Trial Phase
Completed NCT04255225 - Making Activity Time for Cognitive Health N/A
Completed NCT01196442 - Electrical Stimulation Pain Therapy in Treating Chronic Pain and Numbness Caused By Chemotherapy in Patients With Cancer N/A
Completed NCT04064151 - A Research Study for Latina Women Undergoing Breast Cancer Treatment N/A
Withdrawn NCT05344625 - Ketamine-Assisted PsychoTherapy ViAbility in Treating Cancer-related Emotional Distress Early Phase 1
Completed NCT01967836 - Glad Press 'n Seal® as a Temporary Moisture Barrier to Central Lines in Ambulatory Patients N/A
Completed NCT03345264 - The Find Your PATHS (Pragmatic Assessment of a Tool to Help Survivors) to Sexual Health and Parenthood Study N/A
Recruiting NCT03576274 - Combined Technology Enhanced Home Exercise Program and Other Non-pharmacological Intervention for Cancer Survivors N/A
Completed NCT03650322 - Effects of Yoga, Strength Training and Aerobic Exercise on Cognition in Adult Cancer Survivors N/A
Completed NCT03282214 - A Self-Management Energy Conservation Program for Cancer-Related Fatigue Phase 2
Completed NCT03194399 - Development of Personalized Health Care Service in Patients With Breast Cancer N/A
Terminated NCT00006994 - S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat Phase 3
Active, not recruiting NCT04533165 - Virtual Exercise Program to Reduce Cancer Related Fatigue N/A
Active, not recruiting NCT04950608 - Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care Phase 2
Completed NCT03645005 - A Research Study for Latina Women After Breast Cancer Treatment N/A
Terminated NCT02827552 - Description of Individual Radiosensitivity With Molecular Biomarkers in a Pediatric Oncology Population N/A
Recruiting NCT05226078 - The Association Between CBT-I Dose, Sleep Duration, and Fatigue in Breast Cancer Patients N/A
Recruiting NCT02823314 - Effectiveness of Medical Taping Concept in Cancer Patients Phase 0
Completed NCT04230941 - Memory and Attention Adaptation Training-Geriatrics (MAAT-G) N/A
Completed NCT03911921 - RSYR for Fatigue Reduction in Cancer Survivors Phase 2
Completed NCT03198754 - Programmed Environmental Illumination (PEI) of Hospital Rooms to Prevent/Reduce Cancer-Related Fatigue N/A

External Links